Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Staff Accountant 2

BPAS
(Huntingdon Valley PA / Hybrid)

BPAS logo

3(16) Retirement Plan & Customer Liaison

Compass
(Remote / Stratham NH / Hybrid)

Compass logo

Retirement Plan Administrator (Part-Time)

Accelefund, Inc.
(Remote / Lenexa KS)

Accelefund, Inc. logo

Consultant / Account Manager

Spectrum Pension Consultants (part of Daybright Financial)
(Remote / Tacoma WA / CA / OH)

Spectrum Pension Consultants (part of Daybright Financial) logo

Participant Services & Operations Coordinator

Pentegra
(Remote)

Pentegra logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon

What's Next for Drug Pricing in the U.S.?
White & Case LLP via Lexology; registration required Link to more items from this source
June 9, 2021

"Three [proposed] bills would change US antitrust laws to target 'reverse payment' patent settlements, 'product hopping' and 'sham' citizen petitioning. A fourth bill would cap the number of patents in an infringement action resulting from a 'patent dance' information exchange in the abbreviated approval pathway for biosimilars. Supporters claim these bills would target conduct that supposedly prevents or slows competition from less-expensive drugs."

MORE >>

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).